Candesartan Other names: Candesartan

Chemical formula: C₂₄H₂₀N₆O₃  Molecular mass: 440.454 g/mol  PubChem compound: 2541

Therapeutic indications

Candesartan is indicated for:

Primary hypertension

Population group: only adults (18 years old or older)

Essential hypertension

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Heart failure and impaired left ventricular systolic function

Population group: only adults (18 years old or older)

Candesartan is indicated for the treatment of adult patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction ≤40%) when Angiotensin Converting Enzyme (ACE)-inhibitors are not tolerated or as add-on therapy to ACE-inhibitors in patients with symptomatic heart failure, despite optimal therapy, when mineralocorticoid receptor antagonists are not tolerated.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Hypertension

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

Hypertension

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Candesartan is contraindicated in the following cases:

Severe hepatic impairment

Hepatic failure stage IV

Pregnancy

Pregnancy

Cholestasis

Cholestasis

Aliskiren in patients with diabetes mellitus or renal impairment

Aliskiren and additionally at least one of
Diabetes mellitus
at least one of



Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2023: CANDESARTAN CILEXETIL Tablet
Summary of Product Characteristics (SPC) 2023: ATACAND Tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈